Navigation Links
Stray Breast Tumor Cells in Early Chemo Could Be Bad Sign
Date:12/12/2010

here's not a very clear correlation between actually watching the tumor shrink and the number of tumor cells," confirmed Dr. Jay Brooks, chief of hematology/oncology at Ochsner Health System in Baton Rouge, La.

And it's far from clear that this simple blood test would be a good replacement for imaging to track the progress of the cancer, he added.

Nor do CTCs tell you which treatment may be best, like certain other markers, including HER2/neu and estrogen-receptor status, added Armstrong, although he said it might indicate the need for a more aggressive approach.

Still, Armstrong said, "these CTCs are likely to become very important because they're not just a protein. They're the actual cancer cell, so if you can isolate them and measure things that have gone wrong inside the cancer cell, you could eventually use them to guide therapy for an individual. [And] you could monitor it over time especially to assess response to treatment and modify treatment [if necessary]. Cancer cells mutate and can develop abnormalities that can be an Achilles' heel for drugs. Without that information, it's very hard to guide therapy."

Other studies being presented at the symposium confirm the potential importance of CTC levels in predicting the odds for a recurrence, or a patient's general prognosis after treatment.

One report, from German researchers, found that the presence of only a few CTCs in the blood -- this time, involving early-stage patients -- roughly doubled the risk for a recurrence and death. Five or more of the tumor cells increased the chances of a relapse by 400 percent and death by 300 percent.

A study from scientists at the M.D. Anderson Cancer Center at the University of Texas found that metastatic breast cancer patients who had both chemotherapy and transplants of their own stem cells and had CTCs in their blood also tended to fare badly.

The stem cells may be responsible by carrying CTCs from the bone marrow into the b
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Higher co-payments increase chance of early discontinuation of breast cancer therapy
2. Depression drug may relieve pain from breast cancer treatment, U-M study finds
3. Novel imaging technique may reduce lymphedema in breast cancer patients
4. Phase III efficacy data on bevacizumab plus chemotherapy in early breast cancer to be presented
5. Circulating tumor cells predicted recurrence, death in patients with early-stage breast cancer
6. High CTC levels predicted poor outcome in metastatic breast cancer
7. CTCs predict poor outcome from blood stem cell transplantation therapy for metastatic breast cancer
8. Poor breast cancer prognosis associated with presence of circulating tumor, cancer stem cells
9. Trio of drugs may combat triple negative breast cancer
10. Simple fingertip test may identify breast cancer patients at risk for carpal tunnel syndrome
11. FDA Weighs In as Sharing of Breast Milk Booms
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stray Breast Tumor Cells in Early Chemo Could Be Bad Sign
(Date:5/18/2013)... 18, 2013 The product liability attorneys at ... on behalf of consumers nationwide who have sustained serious tendon ... shoes. These cases are all part of MDL 2308 and ... lawsuits will be heard in the U.S. District Court ... Wright & Schulte, LLC specializes in defending the rights of ...
(Date:5/17/2013)... J. Schultz, D.D.S., is making the Laser Assisted New Attachment ... of San Juan Capistrano. The laser surgery disintegrates up ... a scalpel to cut the tissue away. The periodontist ... wavelengths to target the diseased tissue and bacteria while leaving ... in every hundred dental professionals is trained and authorized to ...
(Date:5/17/2013)... May 17, 2013 Stryker hip lawsuit ... year’s Rejuvenate and ABG II Modular-Neck Hip Stem recall continue ... LLP reports. According to court documents, a Case Management ... May 15th, at which time the Court, among other things, ... the litigation must submit Fact Sheets to Defendant and Liaison ...
(Date:5/17/2013)... 17, 2013 Charlotte’s top professional athletes ... with children served by the Muscular Dystrophy Association at ... Tuesday, May 21 at Bank of America Stadium from ... unique social event that pairs top professional athletes and ... an “MDA Buddy” (a local child living with a ...
(Date:5/17/2013)... 2013 Parker Waichman LLP , ... of victims injured by defective medical devices, notes that ... in a May 16, 2013, statement that ... ceramic-on-metal hip replacement products; specifically, the metal liners in ... Hip System will no longer be available worldwide after ...
Breaking Medicine News(10 mins):Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4Health News:San Clemente, CA Periodontist, Dr. Allen J. Schultz, Now Provides Laser Gum Disease Treatment to Southern Orange County Periodontal Disease Patients 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation 3Health News:MDA Hosts Annual Charlotte Muscle Team Event 2Health News:MDA Hosts Annual Charlotte Muscle Team Event 3Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 2Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 3
... continued to pay for sex despite having steady partners, according to ... to visiting prostitutes recently while 27 percent admitted that it was ... paying for sex were in a concurrent relationship," said Dr Tamsin ... sex while at home or abroad, but used condoms in most ...
... infamous for food poisoning that kills hundreds of ... into and multiply inside macrophages, the very immune ... and destroy invading microbes. ,Just how ... to prey complicit in promoting infection, has seemed ...
... the University of Michigan Health System finds that treating ... alpha blocker has many benefits// and can even allow ... the US, the disease affects 13 percent of men ... by minimally invasive surgery, but research suggests that medicines ...
... of public health interventions can cost hundreds of lives, especially ... if the science is good, we should act before the ... required before new interventions are implemented. But in 2003, the ... parachutes to show that situations still exist where such trials ...
... Loma Linda University (LLU) shows that adding just a handful ... oxidation of blood lipids// , thus helping reduce the risk ... in part due to the pecan’s significant content of vitamin ... of phytochemicals that can have a unique effect on the ...
... stress syndrome, better known as shin splints, in distance runners ... in Messina, Italy. ,According to the study, medial ... injuries that may be found in athletes and accounts for ... ,For the study, high-resolution CT of both tibiae (shin bones) ...
Cached Medicine News:Health News:An Infectious Agent of Deception, Exposed Through Proteomics 2Health News:Drugs May Help Urinary Disease 2Health News:Antioxidant-Rich Pecans Protect Against Unhealthy Oxidation in the Body 2
(Date:5/17/2013)... 17, 2013  Atossa Genetics, Inc. (NASDAQ: ATOS ... Kyle Guse , Chief Financial Officer & General Counsel, ... on Thursday, May 30, 2013, in New York ... The Company,s presentation is scheduled to begin at 3:30 ... To access the webcast, go to www.atossagenetics.com . ...
(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ... today that the United States Food and Drug Administration ... for ORMD-0801, its oral insulin capsule. "We ... proceed," stated Nadav Kidron , CEO ... for Oramed and we look forward to continuing to ...
(Date:5/17/2013)... NATICK, Mass. , May 17, 2013  Boston ... to participate at the annual EuroPCR Scientific Program May ... "We are pleased to present a particularly rich and ... Keith Dawkins , M.D., global chief ... several trials will be presented, including the NG PROMUS ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
... Worldwide, Inc. (NYSE: OWW ) will host a conference call to discuss the ... Wednesday, May 5, 2010 at 10:00 a.m. EDT ( 9:00 a.m. CDT ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20070813/AQM125LOGO ) , ... A live webcast of the call can be accessed through the Orbitz Worldwide Investor Relations ...
... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), a biopharmaceutical company ... Paul F. Truex , Anthera,s President and Chief Executive Officer will present ... MA on Monday, May 3, 2010 at approximately ... , , ...
Cached Medicine Technology:Orbitz Worldwide, Inc. to Host First Quarter 2010 Earnings Call on May 5 2Orbitz Worldwide, Inc. to Host First Quarter 2010 Earnings Call on May 5 3Anthera Pharmaceuticals to Present at Deutsche Bank Securities' 35th Annual Health Care Conference 2
Rubella IgG II ELISA....
The Urine Legionella Antigen ELISA kit detects the presence of Legionella pneumophila serogroup1 antigen in urine....
Mumps IgG ELISA....
Measles IgG ELISA....
Medicine Products: